PMC:7534795 / 39435-39596 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T183","span":{"begin":87,"end":95},"obj":"Body_part"}],"attributes":[{"id":"A183","pred":"fma_id","subj":"T183","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"Table 6 Summary of the ongoing trials investigating pharmacological agents targeting a cytokine storm and acute cardiac injury secondary to SARS-CoV-2 infection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T314","span":{"begin":120,"end":126},"obj":"Disease"},{"id":"T315","span":{"begin":140,"end":148},"obj":"Disease"},{"id":"T316","span":{"begin":151,"end":160},"obj":"Disease"}],"attributes":[{"id":"A314","pred":"mondo_id","subj":"T314","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A315","pred":"mondo_id","subj":"T315","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A316","pred":"mondo_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Table 6 Summary of the ongoing trials investigating pharmacological agents targeting a cytokine storm and acute cardiac injury secondary to SARS-CoV-2 infection."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T262","span":{"begin":85,"end":86},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Table 6 Summary of the ongoing trials investigating pharmacological agents targeting a cytokine storm and acute cardiac injury secondary to SARS-CoV-2 infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T284","span":{"begin":0,"end":161},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 6 Summary of the ongoing trials investigating pharmacological agents targeting a cytokine storm and acute cardiac injury secondary to SARS-CoV-2 infection."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T151","span":{"begin":87,"end":101},"obj":"Phenotype"}],"attributes":[{"id":"A151","pred":"hp_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"Table 6 Summary of the ongoing trials investigating pharmacological agents targeting a cytokine storm and acute cardiac injury secondary to SARS-CoV-2 infection."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1364","span":{"begin":112,"end":126},"obj":"Disease"},{"id":"1365","span":{"begin":140,"end":160},"obj":"Disease"}],"attributes":[{"id":"A1364","pred":"tao:has_database_id","subj":"1364","obj":"MESH:D006331"},{"id":"A1365","pred":"tao:has_database_id","subj":"1365","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 6 Summary of the ongoing trials investigating pharmacological agents targeting a cytokine storm and acute cardiac injury secondary to SARS-CoV-2 infection."}